Borer Denton & Associates’s CVS Health CVS Stock Holding History

Borer Denton & Associates’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.41M	Sell	33,531 -288	-0.9%	-$22.2K	0.86%	29
2025 Q4	$2.68M	Buy	33,819 +8,187	+32%	+$645K	0.9%	31
2025 Q3	$1.93M	Buy	25,632 +1,200	+5%	+$82.2K	0.64%	32
2025 Q2	$1.69M	Sell	24,432 -2,885	-11%	-$189K	0.58%	33
2025 Q1	$1.85M	Sell	27,317 -6,886	-20%	-$412K	0.65%	32
2024 Q4	$1.54M	Sell	34,203 -14,807	-30%	-$831K	0.53%	35
2024 Q3	$3.08M	Sell	49,010 -21,701	-31%	-$1.27M	1.05%	27
2024 Q2	$4.18M	Sell	70,711 -6,930	-9%	-$433K	1.52%	23
2024 Q1	$6.19M	Sell	77,641 -275	-0.4%	-$21K	2.19%	19
2023 Q4	$6.15M	Sell	77,916 -2,175	-3%	-$155K	2.36%	18
2023 Q3	$5.59M	Sell	80,091 -1,344	-2%	-$95.2K	2.31%	19
2023 Q2	$5.63M	Buy	81,435 +1,025	+1%	+$72.9K	2.22%	19
2023 Q1	$5.98M	Buy	80,410 +4,387	+6%	+$368K	2.48%	17
2022 Q4	$7.08M	Buy	76,023 +1,275	+2%	+$123K	3.14%	16
2022 Q3	$7.13M	Buy	74,748 +2,590	+4%	+$256K	3.55%	13
2022 Q2	$6.69M	Sell	72,158 -50	-0.1%	-$4.88K	3.22%	13
2022 Q1	$7.31M	Buy	+72,208	New	+$7.59M	3.07%	15

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Borer Denton & Associates's CVS Position: Q1 2026 in Review

Borer Denton & Associates reduced its CVS Health (CVS) stake by 0.85% in Q1 2026, selling an estimated $22.2K and leaving 33,531 shares worth $2.41M. The position accounts for 0.86% of the portfolio, ranked #29.

Borer Denton & Associates first reported a position in CVS in Q1 2022 and has held it in 17 quarters since. The position peaked at $7.31M in Q1 2022. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Borer Denton & Associates held 33,531 shares of CVS Health worth $2.41M as of Q1 2026.
Borer Denton & Associates sold 288 CVS Health shares in Q1 2026, an estimated $22.2K.
CVS Health made up 0.86% of Borer Denton & Associates's portfolio in Q1 2026, its #29 holding.
Borer Denton & Associates first reported a position in CVS Health in Q1 2022 and has held it in 17 quarters since.
Borer Denton & Associates's CVS Health position peaked at $7.31M in Q1 2022.
1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Borer Denton & Associates's 13F filing for Q1 2026, filed 12 May 2026.